Peter Spargo

From January to October 2015, Dr Spargo also served as Senior Vice President, CMC at Spinifex Pharmaceuticals, a biotechnology company that was acquired by Novartis International. From 2011 to 2013, Dr Spargo was Senior Vice President, CMC at Creabilis, a pharmaceutical company. Dr Spargo received a PhD in synthetic organic chemistry from Cambridge University.